HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 09-07-2012, 02:37 AM   #21
Mandamoo
Senior Member
 
Mandamoo's Avatar
 
Join Date: Jul 2011
Location: Melbourne, Australia
Posts: 432
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

Ok - there is a financial benefit which always seems to win but
what about the large study that looked at tykerb vs in the adjuvant setting which found herceptin was more effective than tykerb? I'm sorry I can't remember the name of the study?
I for one seem to respond better to tykerb and hope to keep it in my kit for sometime.
__________________
Amanda xx
40 year old Mum to three gorgeous kids - son 5 and daughters 8 and 11
Wife to my wonderfully supportive husband of 17 years!
22 February 2011 - Diagnosed Early Breast Cancer IDBC Stage2b (ER/PR -ve, Her2+ve +++) - 38 years old
(L) skin sparing mastectomy with tissue expander, axilla clearance (2/14 affected) clear margins.
Fec*3, Taxotere and herceptin*2 - stopped due to secondary diagnosis

June 24 2011 Stage IV - Skin met, axilla node, multiple lung lesions

Bolero3 trial - Navelbine, Hereptin weekly, daily Everolimus/Placebo
February 2012 - July 2012 Tykerb and Xeloda - skin mets resolved, Lungs initially dramatically reduced but growing again
August 2012 (turn 40!) tykerb and herceptin (denied compassionate use of TDM1) while holidaying in Italy!
September 2012 - January 2013 TDM1 as part of the Th3resa trial - lymph nodes resolved, lungs slowly progressing.
January 2013 - herceptin, carboplatin and Perjeta (compassionate access)
April 2013 - Some progression in lungs and lymph nodes - Abraxane, Herceptin and Perjeta
July 2013 - mixed response - dramatic reduction of most lung disease, progression of smaller lung nodules and cervical and hilar nodes - ? Add avastin.
Mandamoo is offline   Reply With Quote
Old 09-07-2012, 02:58 AM   #22
gdpawel
Senior Member
 
gdpawel's Avatar
 
Join Date: Aug 2006
Location: Pennsylvania
Posts: 1,080
You bring up a perfect point about average population studies. Average population studies point to Herceptin being more effective than Tykerb, while in your case Tykerb seems to respond better. The reason so many patients suffer from chemotherapy is that treatment (based on those average population studies) usually follows a standard protocol and many patients have to try two or three kinds before one works (if any work), making them sicker in the process. Anti-cancer drugs should work best for you as an individual, not average patients from average population studies.

As increasing numbers and types of anti-cancer drugs are developed, oncologists become increasingly likely to misuse them in their practice. There is seldom a "standard" therapy which has been proven to be superior to any other therapy. When all studies are compared by meta-analysis, there is no difference. What may work for one cancer patient, may not work for another.

In a TheScientist.com article, "Crowdsourcing Drug Discovery," it was commented that for the last 50 years, randomized controlled trials have been the unquestioned gold standard, when in fact they have become a fiercely defended relic of our ignorance in 1962 when (US) Congress empowered the FDA to begin regulating efficacy.

At that time, it was a "best we could do" solution - but now? They take too long, cost too much, are fraught with unsolveable ethical problems that patients and many physicians dislike, and cannot ask the patient-specific molecular questions we now know need to be asked and answered.

Yet, most clinical trialists and the FDA cling to these crude, simplistic tools like an irrational safety blanket. If we can't reach agreement that clinical methodologies must adapt to new knowledge of the biology of disease, and that the way drug development is regulated must rapidly adapt in much the same way, then our ability to accelerate advances in medicine will remain stagnant.

A key point in this article is that the new system should be patient-centric. It has to be something patients will not only tolerate, or enter under duress, but rather a system that makes sense to them personally - even when they are not yet facing a serious or terminal condition. If real patients are left out of the process of change, we will likely end up in the wrong place again.

http://www.f1000scientist.com/article/display/57646/

I heard women who were bumped from the T-DM1 clinical trial because of disease progression, which meant that their cancer was growing despite the drug. Bumped off the trial because of disease progression? Wonder how many patients there were?

Response rates (how much a tumor decreased in size) can be inflated when excluding patients during clinical trials (evaluable patients). Patients not considered "evaluable" are often those who do not get the benefit of an entire treatment plan. The response rate is calculated after removing patients, who die or have been excluded, from the calculation. This inflates the response rate.

But clinical oncologists want to publish their papers. They need to report on the outcomes of their experiments, but if they had to wait for survival data, it could take years until all the data was aggregated. That wouldn't bode well for them to participate in pharma-sponsored trials in the future.

Response rates give clinical oncologists the opportunity to take a more optimistic look at therapies that have limited success. They can describe results as being complete remission, partial remission or simply clinical improvement.

If they treat all patients for three weeks, they can fairly evaluate the efficacy of a compound, which takes that lone (on average) before it can be regarded as effective. If they disregard all patients who die or were excluded after onset of therapy, and include only those treated three weeks or more, they can improve their data.

To justify their existence, they have to publish papers. That's what they do.
gdpawel is offline   Reply With Quote
Old 09-07-2012, 08:56 PM   #23
Mandamoo
Senior Member
 
Mandamoo's Avatar
 
Join Date: Jul 2011
Location: Melbourne, Australia
Posts: 432
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

It is definitely food for thought. Thanks for the information. I wish I had got this disease 20 years down the track - please keep fighting for personalised medicine - it has to be that way.
I have to say that my appointment with the Principal Investigator for the Theresa trial this week was interesting as for the first time I saw genuine interest in the tumour specific profiling I have had partially done and wishes for more genetic information. I have to hope that just maybe, there is something out there that may work for me.
__________________
Amanda xx
40 year old Mum to three gorgeous kids - son 5 and daughters 8 and 11
Wife to my wonderfully supportive husband of 17 years!
22 February 2011 - Diagnosed Early Breast Cancer IDBC Stage2b (ER/PR -ve, Her2+ve +++) - 38 years old
(L) skin sparing mastectomy with tissue expander, axilla clearance (2/14 affected) clear margins.
Fec*3, Taxotere and herceptin*2 - stopped due to secondary diagnosis

June 24 2011 Stage IV - Skin met, axilla node, multiple lung lesions

Bolero3 trial - Navelbine, Hereptin weekly, daily Everolimus/Placebo
February 2012 - July 2012 Tykerb and Xeloda - skin mets resolved, Lungs initially dramatically reduced but growing again
August 2012 (turn 40!) tykerb and herceptin (denied compassionate use of TDM1) while holidaying in Italy!
September 2012 - January 2013 TDM1 as part of the Th3resa trial - lymph nodes resolved, lungs slowly progressing.
January 2013 - herceptin, carboplatin and Perjeta (compassionate access)
April 2013 - Some progression in lungs and lymph nodes - Abraxane, Herceptin and Perjeta
July 2013 - mixed response - dramatic reduction of most lung disease, progression of smaller lung nodules and cervical and hilar nodes - ? Add avastin.
Mandamoo is offline   Reply With Quote
Old 09-09-2012, 06:34 PM   #24
phil
Senior Member
 
Join Date: Nov 2010
Posts: 393
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

I havent heard a $ issue w/ tyk in my discussions w/ several top docs; but more that they dislike its common , nasty se/. and that it doesnt work long for many. There are exceptions, some get long response . they find more broad + response w/ herc, and fewer s/e.
Mandamoo, i think it's a lousy system in many ways. here in US genentech is re-opening exp access, and comp use. yet theparent co, Roche , can deny thiese programs in other countries. they expnad world-wide to reap profits, but that expansion doesnt cover merciful tx. Not thier priority. Early in our battle i usd to say , " Do you think some accountant at Roche Holding AG in Zurich gives two hoots about Lorraine ? " ; they just want a return on thier investment as soon as possible. I hope we continue to publicize this. over the past yr, Severin Schwan, Roche CEO has repaetedly said his co. is all about " Personalized Health Care " We called him on it at our BIO protest, and will continue to !
phil is offline   Reply With Quote
Old 09-10-2012, 03:54 PM   #25
hutchibk
Senior Member
 
hutchibk's Avatar
 
Join Date: Oct 2005
Posts: 3,519
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

Just FYI, Tykerb (with first Xeloda and then Herceptin) works long term for some... 3 years for me. Avoided WBR because of Tykerb, was able to do 'wack-a-mole' instead. For me, and several others, my oncs have loved it. For others, it hasn't worked as well. Same as other treatments. Not bad SEs either. Just one girls opinion.

Also, the folks who have heart congestion/failure with Herceptin over time, be sure at first that you are taking exceptional care of your teeth. There is a known connection to less cared for teeth (brush 2x a day, for 2 min each time, and floss once a day.... all this is minimum). We are not immune to normal folks problems and we know that tooth health is directly connected to heart failure. We are probably even more affected by regular issues, + Herceptin issues added on top. Just one girls opinion.
__________________
Brenda

NOV 2012 - 9 yr anniversary
JULY 2012 - 7 yr anniversary stage IV (of 50...)

Nov'03~ dX stage 2B
Dec'03~
Rt side mastectomy, Her2+, ER/PR+, 10 nodes out, one node positive
Jan'04~
Taxotere/Adria/Cytoxan x 6, NED, no Rads, Tamox. 1 year, Arimadex 3 mo., NED 14 mo.
Sept'05~
micro mets lungs/chest nodes/underarm node, Switched to Aromasin, T/C/H x 7, NED 6 months - Herceptin only
Aug'06~
micro mets chest nodes, & bone spot @ C3 neck, Added Taxol to Herceptin
Feb'07~ Genetic testing, BRCA 1&2 neg

Apr'07~
MRI - two 9mm brain mets & 5 punctates, new left chest met, & small increase of bone spot C3 neck, Stopped Aromasin
May'07~
Started Tykerb/Xeloda, no WBR for now
June'07~
MRI - stable brain mets, no new mets, 9mm spots less enhanced, CA15.3 down 45.5 to 9.3 in 10 wks, Ty/Xel working magic!
Aug'07~
MRI - brain mets shrunk half, NO NEW BRAIN METS!!, TMs stable @ 9.2
Oct'07~
PET/CT & MRI show NED
Apr'08~
scans still show NED in the head, small bone spot on right iliac crest (rear pelvic bone)
Sept'08~
MRI shows activity in brain mets, completed 5 fractions/5 consecutive days of IMRT to zap the pesky buggers
Oct'08~
dropped Xeloda, switched to tri-weekly Herceptin in combo with Tykerb, extend to tri-monthly Zometa infusion
Dec'08~
Brain MRI- 4 spots reduced to punctate size, large spot shrunk by 3mm, CT of torso clear/pelvis spot stable
June'09~
new 3-4mm left cerrebellar spot zapped with IMRT targeted rads
Sept'09~
new 6mm & 1 cm spots in pituitary/optic chiasm area. Rx= 25 days of 3D conformal fractionated targeted IMRT to the tumors.
Oct'09~
25 days of low dose 3D conformal fractionated targeted IMRT to the bone mets spot on rt. iliac crest that have been watching for 2 years. Added daily Aromasin back into treatment regimen.
Apr'10~ Brain MRI clear! But, see new small spot on adrenal gland. Change from Aromasin back to Tamoxifen.
June'10~ Tumor markers (CA15.3) dropped from 37 to 23 after one month on Tamoxifen. Continue to monitor adrenal gland spot. Remain on Tykerb/Herceptin/Tamoxifen.
Nov'10~ Radiate positive mediastinal node that was pressing on recurrent laryngeal nerve, causing paralyzed larynx and a funny voice.
Jan'11~ MRI shows possible activity or perhaps just scar tissue/necrotic increase on 3 previously treated brain spots and a pituitary spot. 5 days of IMRT on 4 spots.
Feb'11~ Enrolled in T-DM1 EAP in Denver, first treatment March 25, 2011.
Mar'11~ Finally started T-DM1 EAP in Denver at Rocky Mountain Cancer Center/Rose on Mar. 25... hallelujah.

"I would rather be anecdotally alive than statistically dead."
hutchibk is offline   Reply With Quote
Old 09-13-2012, 07:17 PM   #26
Kayakr01
Member
 
Kayakr01's Avatar
 
Join Date: Mar 2010
Posts: 5
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

I will be watching this site and thread closely now. My fiance' is to receive t-dm1 therapy as part of expanded access program, I believe.

Tomorrow 9/14 she will receive multiple baseline tests, and if there are no issues uncovered, proceed with infusion tomorrow afternoon of this t-dm1 treatment.

The heart damage debate has my attention. She had Herceptin only, about a month ago. Unlike the prior times she received it, for the first 24 hours she had nausea, chills, fever around 100, and 'chest pressure'; she also felt pretty rotten for about a week. I believe it was a mild infusion reaction.

The doctors will discuss this tomorrow with her. Jen is aware of the conversation about heart damage; however at present wants to move forward.

It is really scary to be in this place; so many unknowns and it seems like such a dart-throwing approach to medicine; I still want to believe the underlying cause needs discovered; that all these chemos are not only just bandaids; they might possibly be aggravating some cancers. There is not enough focus on the whole body!

I believe a rigorous exercise program and super-organic diet should be mandatory for anyone who fights a cancer, of any kind. There are too many variables out there to rely on a single treatment or small variety of treatments as a cure.

I pray those involved are making decisions based on a cure; not on making their mortgage and car payments.

Bob
__________________
Bob
Jen's Guy

-11/09 Pregnancy
-12/10 lump in right breast found
-02/11 Needle biopsy pos for HER2 stage 1
02/10-07-10: Taxol 8 weeks
07/21/10 healthy baby Molly born
08/10 - 05/11 Chemo only: adriamycin and Citoxan
then? Herceptin, localized radiation
-05/11 Stage 4, lung mass
-07/30/11 CLINICAL TRIAL: EMILIA/TDM4370g
-08/6/11 Emergency room visit for severe stomach pain; prognosis in progress
09-11 Prognosis: too much Xeloda (cabecitabine)
-01-16-12 Middle lobectomy for tumor
02-7-12 Frequently tired and nauseous though not on any chemo for 8 weeks
-05/2012 clear Pet Scan/MRI post lobectomy
08/2012 Scan reveals progression to lung and liver.
8/24/2012 resume Herceptin; Tykerb pending. First round created heavy chest, chills, and fever (Reaction). Heart test in 3 weeks.
9/4/12 nausea.
09/14/12: T-DM1 Candidate testing; start trial
10/18/12 2.5 cycles in to TH3RESA study; lots of chest pressure; signs of bruising; infusion effects last 3-5 days
2/2013 5 weeks whole brain radiation therapy due to 8 visible brain tumors
9/12/13 Cyberknife treatment for three tumors
Kayakr01 is offline   Reply With Quote
Old 09-14-2012, 07:41 AM   #27
sarah
Senior Member
 
Join Date: Sep 2005
Location: france
Posts: 1,648
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

Wow! great discussion! yes we all hope for more directed, personalized treatment.
Just wanted to point out that I had a heart problem, heart attack (didn't know I'd had one!!), 100% blocked artery, had to have an angioplasty and stent put in.
I saw 3 different cardiologists at 2 different hospitals and of course asked the obvious question, particularly since I'd been on Herceptin for 6 years but had now been off it for nearly 2 - "is it the Herceptin?" and all 3 immediately said "No! it's the radiation" 2 of them showed me my radiation tatoos. I had heart sonograms (echographie du coeur) every 3 months during Herceptin and it was always good and constant.
Brenda thanks for the reminder about the teeth, I am pretty good about it.
So I think anyone who had radiation, particularly outside the breast area, should be followed by a cardiologist and be aware of chest pains and breathing.
While I'm sorry my heart and lungs were damaged, I'm just grateful that after the recurrence and the very scary news it came with, that I got Herceptin for so long and radiation despite radiation's side effects, which by the way the New York Times (and I'm sure other papers) are talking a lot about.
I'll make sure that everyone in our support group, particularly those who take Herceptin and have radiation, know the importance of seeing a cardiologist and not just for the Muga or echo.
Love this site and appreciate your info, great that you keep us so informed.
I am so terribly sorry Greg and Phil for your losses and send you a cyber hug. You are exceptional people to keep so involved and it's so appreciated.
health and happiness
Sarah
sarah
__________________
sarah is offline   Reply With Quote
Old 09-17-2012, 08:10 AM   #28
phil
Senior Member
 
Join Date: Nov 2010
Posts: 393
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

Bob, please keep us posted on your wifes t dm-1 tx. Good luck, God Bless . It is a great drug for her2, . Recent NY Times article ( peter canellos , (sp ?), June article ) quoted researchers as saying it has the BEST survival rates so far for ANY her2 drug ! , and in EMILIA decisively outperformed tykerb/xeloda . L. has been doing great on it for nearly 2 yrs. Some are at 4 yrs and counting. It is very common to have a fever, chills w/in several days of taking t dm-1. That s/e often goes away after several doses as body adjusts to it. We did go to er once or twice w/ fever over 100.5 . no ongoing problem. The one time we ignored the fever , it turned out to be sepsis related to stents L. had , nearly killed her, so follow protocol for fevers !
cardiac risks have to be weighed against risks of a very aggressive cancer. Lorraine was in good physical strength prior to cancer , not a smoker, not much of a drinker, regular exerciser. She has passed every echo w/ flying colors . 6 yrs of near continous herc ., last 2 herc w/in t dm-1. My mantra for aggressive cancers is aggressive tx first, w/ as much wholistic living as possible w/in that tx., adding more and more wholistic tx as sxs subside. Conventional tx first, alternative as secondary , for the early part of Stage IV fight. I feel that many cancers will turn out to be related to pervasive chemical pollution in environment, coupled w/ genetic susceptibility , that we cannot avoid simply by diet, exercise , etc. Nothing wrong w/ healthy living, and it can strengthen us greatly for the battle, and future healthier living.
phil is offline   Reply With Quote
Old 09-17-2012, 11:08 AM   #29
StephN
Senior Member
 
StephN's Avatar
 
Join Date: Nov 2004
Location: Misty woods of WA State
Posts: 4,128
Re: Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors

This is a thread that is appropriate for me.

I was on Herceptin for almost 8 years. My MUGA dropped a little once and I took a short Herceptin holiday, then resumed, remaining NED during that time.

I had been taking CoEnzyme Q10 for a couple of years prior to my diagnosis, on the basis that heart problem run in my father's side. Continued to take the supplement most of my 2-year active/chemo/rads treatment time. Still take it.

Also ate heart healthy, low fat diet, which became more organic upon diagnosis.

My curious side has to wonder if factors like family history, diet, exercise level, lifestyle were incorporated into this "evidence," which could combine with the affects of Herceptin for heart failure.

I also had Adriamycin, Taxotere and Taxol, which are also cardiotoxic. In my case there are a number of ways my heart could be affected besides taking Herceptin.

Bob, let us know how it went with the T-DM1.
__________________
"When I hear music, I fear no danger. I am invulnerable. I see no foe. I am related to the earliest times, and to the latest." H.D. Thoreau
Live in the moment.

MY STORY SO FAR ~~~~
Found suspicious lump 9/2000
Lumpectomy, then node dissection and port placement
Stage IIB, 8 pos nodes of 18, Grade 3, ER & PR -
Adriamycin 12 weekly, taxotere 4 rounds
36 rads - very little burning
3 mos after rads liver full of tumors, Stage IV Jan 2002, one spot on sternum
Weekly Taxol, Navelbine, Herceptin for 27 rounds to NED!
2003 & 2004 no active disease - 3 weekly Herceptin + Zometa
Jan 2005 two mets to brain - Gamma Knife on Jan 18
All clear until treated cerebellum spot showing activity on Jan 2006 brain MRI & brain PET
Brain surgery on Feb 9, 2006 - no cancer, 100% radiation necrosis - tumor was still dying
Continue as NED while on Herceptin & quarterly Zometa
Fall-2006 - off Zometa - watching one small brain spot (scar?)
2007 - spot/scar in brain stable - finished anticoagulation therapy for clot along my port-a-catheter - 3 angioplasties to unblock vena cava
2008 - Brain and body still NED! Port removed and scans in Dec.
Dec 2008 - stop Herceptin - Vaccine Trial at U of W begun in Oct. of 2011
STILL NED everywhere in Feb 2014 - on wing & prayer
7/14 - Started twice yearly Zometa for my bones
Jan. 2015 checkup still shows NED
2015 Neuropathy in feet - otherwise all OK - still NED.
Same news for 2016 and all of 2017.
Nov of 2017 - had small skin cancer removed from my face. Will have Zometa end of Jan. 2018.
StephN is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 04:54 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter